Vikram Kesavabhotla
Stock Analyst at Baird
(3.08)
# 1,125
Out of 4,828 analysts
46
Total ratings
45.45%
Success rate
1.47%
Average return
Main Sectors:
Stocks Rated by Vikram Kesavabhotla
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SPOT Spotify Technology | Maintains: Outperform | $700 → $730 | $648.25 | +12.61% | 3 | May 1, 2025 | |
| IAS Integral Ad Science Holding | Downgrades: Neutral | $16 → $9 | $7.72 | +16.58% | 2 | Mar 28, 2025 | |
| DV DoubleVerify Holdings | Downgrades: Neutral | $20 → $14 | $13.34 | +4.95% | 4 | Mar 28, 2025 | |
| TTD The Trade Desk | Maintains: Outperform | $160 → $145 | $71.04 | +104.11% | 4 | Feb 13, 2025 | |
| NFLX Netflix | Maintains: Outperform | $875 → $1,200 | $1,140.22 | +5.24% | 2 | Jan 22, 2025 | |
| GDDY GoDaddy | Maintains: Outperform | $200 → $225 | $182.60 | +23.22% | 8 | Nov 19, 2024 | |
| ROKU Roku, Inc. | Upgrades: Outperform | $70 → $90 | $60.93 | +47.71% | 3 | Nov 18, 2024 | |
| DOCS Doximity | Maintains: Outperform | $41 → $45 | $59.19 | -23.97% | 3 | Sep 17, 2024 | |
| DH Definitive Healthcare | Maintains: Neutral | $6 → $5 | $3.69 | +35.50% | 4 | Aug 7, 2024 | |
| HIMS Hims & Hers Health | Initiates: Neutral | $10 | $51.96 | -80.75% | 1 | Apr 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $50 | $27.18 | +83.96% | 1 | Apr 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $23 | $5.68 | +304.93% | 1 | Apr 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $4.32 | +38.89% | 4 | Jun 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $6 → $5 | $3.54 | +41.24% | 2 | May 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $3 | $3.02 | -0.66% | 3 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $30 | $11.98 | +150.42% | 1 | Jul 23, 2021 |
Spotify Technology
May 1, 2025
Maintains: Outperform
Price Target: $700 → $730
Current: $648.25
Upside: +12.61%
Integral Ad Science Holding
Mar 28, 2025
Downgrades: Neutral
Price Target: $16 → $9
Current: $7.72
Upside: +16.58%
DoubleVerify Holdings
Mar 28, 2025
Downgrades: Neutral
Price Target: $20 → $14
Current: $13.34
Upside: +4.95%
The Trade Desk
Feb 13, 2025
Maintains: Outperform
Price Target: $160 → $145
Current: $71.04
Upside: +104.11%
Netflix
Jan 22, 2025
Maintains: Outperform
Price Target: $875 → $1,200
Current: $1,140.22
Upside: +5.24%
GoDaddy
Nov 19, 2024
Maintains: Outperform
Price Target: $200 → $225
Current: $182.60
Upside: +23.22%
Roku, Inc.
Nov 18, 2024
Upgrades: Outperform
Price Target: $70 → $90
Current: $60.93
Upside: +47.71%
Doximity
Sep 17, 2024
Maintains: Outperform
Price Target: $41 → $45
Current: $59.19
Upside: -23.97%
Definitive Healthcare
Aug 7, 2024
Maintains: Neutral
Price Target: $6 → $5
Current: $3.69
Upside: +35.50%
Hims & Hers Health
Apr 11, 2023
Initiates: Neutral
Price Target: $10
Current: $51.96
Upside: -80.75%
Apr 11, 2023
Initiates: Outperform
Price Target: $50
Current: $27.18
Upside: +83.96%
Apr 11, 2023
Initiates: Outperform
Price Target: $23
Current: $5.68
Upside: +304.93%
Jun 22, 2022
Maintains: Neutral
Price Target: $7 → $6
Current: $4.32
Upside: +38.89%
May 16, 2022
Downgrades: Neutral
Price Target: $6 → $5
Current: $3.54
Upside: +41.24%
Nov 16, 2021
Downgrades: Neutral
Price Target: $10 → $3
Current: $3.02
Upside: -0.66%
Jul 23, 2021
Initiates: Outperform
Price Target: $30
Current: $11.98
Upside: +150.42%